Business
Pfizer to seek COVID-19 vaccine approval ‘within days’ as trial shows jab 95 per cent effective – PerthNow
Pfizer and BioNTech COVID-19 vaccine could be submitted for approval ‘within days’ as a final trial reveals it is 95 percent effective. US authorities say it could…
Pfizer Inc and BioNTech could secure emergency US and European authorisation for their COVID-19 vaccine next month after final trial results showed a 95 per cent success rate and no serious side effects.
The vaccine’s efficacy was found to be consistent across different ages and ethnicities – a promising sign given the disease has disproportionately hurt the elderly and certain groups including black people.
The US Food and Drug Administration could grant emergency-use by the middle of December,…
Continue Reading
